Chinese Hepatolgy ›› 2026, Vol. 31 ›› Issue (9): 1277-1282.

• Liver Failure • Previous Articles     Next Articles

Development of a nomogram prediction model for multidrug-resistant infection in patients with HBV-related acute-on-chronic liver failure

Chen Lingxin, Li Na, Ma Congxian, Tang Xiaohong, Liu Cuihua   

  1. Mianyang Hospital Affiliated to Medical College of University of Electronic Science and Technology·Mianyang Central Hospital , Mianyang 621000,China
  • Received:2025-11-07 Online:2026-09-30 Published:2026-11-16
  • Contact: Liu Cuihua,Email: 1803298604@qq.com

Abstract: Objective This study aimed to develop and validate a nomogram for predicting multidrug-resistant organism (MDR) infection in patients with hepatitis B virus-related acute-on-chronic liver failure (HBV-ACLF), so as to provide an evidence-based tool for the targeted prevention of MDR infections. Methods A retrospective study was conducted on patients with HBV-ACLF (diagnosed according to the EASL and APASL 2019 criteria), admitted to Mianyang Hospital and Mianyang Central Hospital between January 2021 and January 2025. MDR infections occurring during hospitalization were assessed. Clinical data, including age, gender, BMI, smoking, and alcohol history, were collected from electronic medical records. Multivariable logistic regression was used to identify independent risk factors for MDR infection and to construct a nomogram. The model's performance was assessed using calibration curves, the receiver operating characteristic (ROC) curve, and decision curve analysis (DCA). Results The study included 295 HBV-ACLF patients; 182 (61.69%) were male and 113 (38.31%) were female. MDR infection occurred in 56 patients, with an incidence of 18.98%. Multivariable analysis identified the following independent risk factors (all P<0.05): high COSSH-ACLF score (OR=2.781, 95% CI: 1.539~5.027), use of broad-spectrum antibiotics for ≥7 days (OR=2.221, 95% CI: 1.256~3.929), exposure to carbapenems (OR=1.827, 95% CI: 1.104~3.024), glucocorticoid therapy (OR=1.505, 95% CI: 1.039~2.180), and multiple organ failure (OR=1.424, 95% CI: 1.033~1.965). The developed nomogram demonstrated good performance: the calibration curve showed high agreement between predicted and actual probabilities (mean absolute error = 0.009), the C-index was 0.885, and the area under the ROC curve was 0.885 (95% CI: 0.698~0.783) with a sensitivity of 0.857 and specificity of 0.899. Decision curve analysis indicated a superior net benefit within a risk threshold probability range of 0.05 to 0.40. Conclusion The constructed nomogram provides a reliable tool with good calibration, discrimination, and potential clinical utility for predicting the risk of MDR infection in patients with HBV-ACLF.

Key words: HBV-related acute-on-chronic liver failure, Multidrug-resistant infection, Nomogram prediction model